Non-insulin oral drug(s)-Actos (Pioglitazone) Posts on Medivizor

Canagliflozin – an effective and safe treatment for late type 2 diabetes

Posted by Medivizor on Jul 2, 2015 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the effectiveness and safety of canagliflozin (Invokana) as a treatment for late type 2 diabetes. Some background Metformin (Glucophage) is typically the first treatment for type 2 diabetes that cannot be controlled by lifestyle alterations alone. Commonly, additional drugs are eventually...

Is Januvia and Actos combined therapy better than monotherapy?

Posted by Medivizor on Oct 11, 2013 in Diabetes mellitus | 0 comments

In a nutshell This trial investigated the safety and efficacy of combined therapy with sitagliptin (Januvia) and pioglitazone (Actos) in type 2 diabetes mellitus (T2DM). Some background T2DM is a condition in which the cells of the body are failing to use insulin properly (insulin resistance), resulting in high blood sugar levels. Therefore, T2DM...

Non-insulin oral drug(s)-Actos (Pioglitazone) Posts on Medivizor

Canagliflozin – an effective and safe treatment for late type 2 diabetes

Is Januvia and Actos combined therapy better than monotherapy?

Categories

Recent Posts

Archives

Non-insulin oral drug(s)-Actos (Pioglitazone) Posts on Medivizor

Canagliflozin – an effective and safe treatment for late type 2 diabetes

Is Januvia and Actos combined therapy better than monotherapy?

Categories

Recent Posts

Archives

Thanks for your interest in Medivizor

Invalid email